IL17A and Buschke-Ollendorff syndrome: However, following bronchiolar injury, ECP was ineffective at attenuating BOS and failed to reduce IL-17A+CD4+ or IFN-γ+CD8+ T cell intragraft accumulation in DCNΔ/Δ recipients (Figure 3, B–E).